Showing results (2271-2280 of 2,960) with videos related to

Sort By:
Pageof 296
American Journal of Otolaryngology|December 4, 2025
Prevention of hypoacusis after radiochemotherapy for head and neck squamous cell carcinomaRomina Mastronicola, Maëlys Bresson, Elise Kayser, et al.
Data in Brief|July 17, 2025
French agroclimatic research network datasetCarina Furusho-Percot, Olivier Maury, Vincent Minet, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|September 13, 2023
Clinics dedicated to transition preparation for adolescents and young adults with chronic conditions: Factors influencing their useEnora Le Roux, Aurélie Bourmaud, Paul Jacquin, et al.
High Altitude Medicine & Biology|December 16, 2003
Effects of intermittent exposure to high altitude on pulmonary hemodynamics: a prospective studyAkpay S Sarybaev, Grzegorz Palasiewicz, Dinara A Usupbaeva, et al.
BMJ Open|December 1, 2018
Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism: protocol for a systematic review and meta-analysis of individual participant dataPhilippe Robin, Maggie Eddy, Lindsey Sikora, et al.
Optics Letters|April 15, 2017
Optical pump-rejection filter based on silicon sub-wavelength engineered photonic structuresDiego Pérez-Galacho, Carlos Alonso-Ramos, Florent Mazeas, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|June 9, 2017
Incremental diagnostic utility of systematic double-bed SPECT/CT for bone scintigraphy in initial staging of cancer patientsCatherine Guezennec, Nathalie Keromnes, Philippe Robin, et al.
AIDS (London, England)|May 26, 2018
Neurodevelopment of breastfed HIV-exposed uninfected and HIV-unexposed children in South AfricaStanzi M le Roux, Kirsten A Donald, Kirsty Brittain, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 19, 2008
Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?Ronan Abgral, Solène Querellou, Gaël Potard, et al.
Blood|October 11, 2007
Erlotinib exhibits antineoplastic off-target effects in AML and MDS: a preclinical studySimone Boehrer, Lionel Adès, Thorsten Braun, et al.
Pageof 296